The stock of Precigen Inc. (NASDAQ:PGEN) increased by $0.04 on Monday to $1.77, up 2.32 percent. The last five days have seen an average of 2,349,394 shares of common stock traded. 10 times new highs were reached in the current year, with a gain of $0.2100. The average number of shares traded over the last 20 days was 2,494,789, while the average volume over the last 50 days totaled 1,786,853.
PGEN stock appreciated 28.28% since last month. On 08/07/23, the company’s shares reached a one-month low of $1.0600. The stock touched a high of $2.90 on 01/23/23, after rallying from a low of $0.81 in 52 weeks. The price of PGEN stock has risen by 16.46% or $0.2100 this year, reaching a new high 10 times. Still, the stock price is down -38.96% from the 52-week high.
Insider Transactions
PGEN stock investors should be aware that Precigen Inc. (PGEN) stock had its last reported insider trading activity 3 days ago on Aug 25. On Aug 25, President and CEO Sabzevari Helen sold 76,969 shares at $1.53 each. This transaction resulted in the insider making $117,763. On Aug 24, Lehr Donald P. sold 10,947 shares at a price of US$1.64. After the transaction, the insider now owns 428,916 shares. Chief Financial Officer Thomasian Harry Jr. had earlier sold 9,045 shares on Aug 24 for $1.64 a share. The transaction was completed for $14,834.
Valuation Metrics
Beta for the stock is 1.84. There are also a few other valuation ratios worth considering, including the trailing price-to-sales (P/S) ratio of 18.10, the price-to-book (PB) ratio of 2.64.
Financial Health
For the three months ended June 29, Precigen Inc.’s current ratio was 3.40. As far as profitability goes, gross margin for the trailing twelve months is 72.60% percent. Based on annual data, it had gross profit of $20.57 million and revenue of $26.91 million.
Investors will also look at the performance of the company’s management in order to determine the potential profitability of their investment. PGEN’s return on assets (ROA) during the last 12 months has been 9.60%. There was a -44.60% return on investment (ROI) in the past year. In the meantime, the return on equity (ROE) for the last 12 months was 14.30%.
Earnings Surprise
According to Precigen Inc.’s quarterly financial report for the quarter that ended June 29. A lower net income was reported in the quarter under review than the previous quarter. Net income for the quarter came in at $1.77 million, while revenues fell by -64.41% to $1.85 million. It was predicted that Precigen Inc.’s quarterly earnings would be -$0.08, but it ended up being -$0.1. EBITDA was -$19.92 million for the quarter. At the end of Precigen Inc.’s most recent quarter ended June 29, its liabilities totaled 41.32 million, while its total debt was $7.97 million. Equity owned by shareholders amounts to $255.48 million.
Technical Picture
Here’s a quick look at Precigen Inc.’s (PGEN) price momentum from a technical perspective. As of 25 August, the RSI 9-day stood at 63.55%, suggesting the stock is Neutral, with a 112.84% historical volatility rate.
The stochastic %K and %D were 79.00% and 75.99% respectively, while the average true range (ATR) was 0.1632. Based on the 14-day stochastic reading of 86.82%, the RSI (14) reading is 62.56%. On the 9-day MACD Oscillator, the stock is at 0.0283, and the 14-day reading is at 0.0773.
Analyst Ratings
In its analyst report released on May 23, 2023, JP Morgan began covering Precigen Inc. (NASDAQ: PGEN). The stock was rated as a Neutral by the brokerage firm. Analysts have assigned Precigen Inc. (PGEN) an Buy rating. PGEN is a stock that is recommended for selling by 0 brokerage firms, while 1 companies recommend holding. The stock is underweighted by 0 analysts. Among the analysts who rate the stock, 0 rates it overweight and 4 others recommend it as a buy.
What is PGEN’s price target for the next 12 months?
The current consensus forecast for the stock is between $6.00 and $14.00, with a median target price of $9.00. In analyzing these forecasts, the average price target given by analysts for Precigen Inc. (PGEN) is $9.50.
